title: [Surgical treatment of intracardiac tumors in 25 patients].
abstract: For most intracardiac tumors, operation is the only means of therapy. In our institute, we have aggressively performed operation for intracardiac tumors regardless of histological type because resection for tumor had a beneficial effect on the hemodynamics with congestive heart failure. Twenty-five cases of cardiac tumors were operated upon from 1980 through 1998. The follow-up period ranged from 2 months to 19 years. The histological diagnoses of the tumors were as follows: benign tumors 24 (myxoma 21, papillary fibroelastoma 1, fibroma 1, angiomyolipoma 1) and malignant tumor (angiosarcoma 1). There was one hospital death in this series. In the New York Heart Association classification, the cardiac performances of intracardiac benign tumors after operation were Class I or II. The results of surgical treatment of intracardiac benign tumors were satisfactory both in short-term and in long-term. On the other hand the long term result of malignant tumor was extremely poor. A patient with angiosarcoma died 8 months later due to bone metastasis.
authors.affiliation: Department of Cardiovascular Surgery, Cardiovascular Center Sakakibara Hospital, Okayama, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Minami
authors.forename: T
authors.initials: T
authors.lastname: Hata
authors.forename: S
authors.initials: S
authors.lastname: Hamanaka
authors.forename: Y
authors.initials: Y
authors.lastname: Tsushima
authors.forename: M
authors.initials: M
authors.lastname: Matsumoto
authors.forename: H
authors.initials: H
authors.lastname: Yoshitaka
authors.forename: G
authors.initials: G
authors.lastname: Chikazawa
authors.forename: K
authors.initials: K
authors.lastname: Nakamura
authors.forename: S
authors.initials: S
authors.lastname: Shinoura
authors.forename: S
authors.initials: S
authors.lastname: Ohtani
mesh_terms: D000368:Aged; D005260:Female; D005500:Follow-Up Studies; D006338:Heart Neoplasms / Q000473:pathology / Q000601:surgery*; D006394:Hemangiosarcoma / Q000473:pathology / Q000601:surgery; D006801:Humans; D008297:Male; D008875:Middle Aged; D009232:Myxoma / Q000473:pathology / Q000601:surgery*; D011379:Prognosis; D013997:Time Factors